Importance of genotyping of Thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy

Importance of genotyping of Thiopurine S-methyltransferase in children with acute lymphoblastic leukaemia during maintenance therapy

INTRODUCTION Thiopurine S-methyltransferase (TPMT) is an enzyme that catalyses the inactivation of mercaptopurine (MP) which is widely used in the treatment of acute lymphoblastic leukaemia (ALL) of childhood. Potentially fatal myelotoxicity may develop after standard doses of MP in TPMT deficient p...

Full description

Bibliographic Details
Main Authors:	Dokmanović Lidija, Janić Dragana, Krstovski Nada, Zukić Branka, Tošić Nataša, Pavlović Sonja
Format:	Article
Language:	English
Published:	Serbian Medical Society 2008-01-01
Series:	Srpski Arhiv za Celokupno Lekarstvo
Subjects:	thiopurine S-methyltransferase pharmacogenetics acute lymphoblastic leukaemia children
Online Access:	http://www.doiserbia.nb.rs/img/doi/0370-8179/2008/0370-81790812609D.pdf

Similar Items

Health Technology Assessment of Thiopurine Methyltransferase Testing for Guiding 6-Mercaptopurine Doses in Pediatric Patients with Acute Lymphoblastic Leukemia
by: Donnan, Jennifer
Published: (2009)

Health Technology Assessment of Thiopurine Methyltransferase Testing for Guiding 6-Mercaptopurine Doses in Pediatric Patients with Acute Lymphoblastic Leukemia
by: Donnan, Jennifer
Published: (2009)

Polymorphisms of the thiopurine S-methyltransferase gene among the Libyan population
by: Hamza Ben Zeglam, et al.
Published: (2015-03-01)

The role of polymorphisms of thiopurine methyltransferase in therapy with Azathioprine: preliminary study
by: Francesca Mortillaro, et al.
Published: (2018-11-01)

Immunoglobulin genes and T-cell receptors as molecular markers in children with acute lymphoblastic leukaemia
by: Lazić Jelena, et al.
Published: (2009-01-01)

Detection of Thiopurine S-Methyltransferase (TPMT) Polymorphisms TPMT*3A, TPMT*3B and TPMT*3C in Children with Acute Lymphoblastic Leukemia
by: Nawar S. Mohammed, et al.
Published: (2018-12-01)

Common Polymorphism’s Analysis of Thiopurine S-Methyltransferase (TPMT) in Iranian Population
by: Mehdi Azad, et al.
Published: (2009-01-01)

Importance of pharmacogenetic markers in the methylenetetrahydrofolate reductase gene during methotrexate treatment in pediatric patients with acute lymphoblastic leukemia
by: Lazić Jelena, et al.
Published: (2017-01-01)

A retrospective study of acute lymphoblastic leukaemia in Paediatric patients at Dr George Mukhari Hospital (2003-2007)
by: Swanepoel, Yolande
Published: (2010)

Individualized therapy: Role of thiopurine S-methyltransferase protein and genetic variants
by: Pavlović Sonja, et al.
Published: (2010-01-01)

Association of TPMT (rs1800460) Gene Polymorphism with Childhood Acute Lymphoblastic Leukemia in a Population from Guilan, Iran
by: Mohammad Hedayati, et al.
Published: (2020-09-01)

6-MP based maintenance therapy of childhood ALL in Slovenia: a retrospective study from 1970 to 2004
by: Nataša Karas Kuželički, et al.
Published: (2015-04-01)

Biophysical characterization of the *5 protein variant of human thiopurine methyltransferase by NMR spectroscopy
by: Gustafsson, Robert
Published: (2012)

Targeted Therapy in Acute Lymphoblastic Leukaemia
by: Ross Salvaris, et al.
Published: (2021-07-01)

Thiopurine S-Methyltransferase Polymorphism in Iraqi Paediatric Patients with Acute Lymphoblastic Leukaemia
by: NAWARS MOHAMMED, et al.
Published: (2019-01-01)

Correlation of thiopurine methyltransferase and inosine triphosphate pyrophosphatase polymorphisms and adverse effects induced by azathioprine treatment in Taiwanese dermatology patients
by: Ting-Shun Wang, et al.
Published: (2014-03-01)

Allergic complications of L-asparaginase therapy in children with acute lymphoblastic leukaemia
by: Konstantinidis Georgios, et al.
Published: (2011-01-01)

Optimisation de la réponse aux thiopurines par la pharmacogénétique : approches in vitro et cliniques
by: Chouchana, Laurent
Published: (2014)

Establishment of human lymphoma cell lines with different thiopurine S-methyltransferase (TPMT) activities and differential proteome analysis after thiopurine exposure.
by: Misdaq, Misbah
Published: (2013)

Hyperoeosinophilia at diagnosis in adolescent acute lymphoblastic leukaemia/lymphoma: A case report and review of the literature
by: Dilshad Jahan, et al.
Published: (2020-01-01)

Editor's Pick: The Role and Regulation of Quiescence in Acute Lymphoblastic Leukaemia
by: Robin Williams, et al.
Published: (2017-08-01)

Papilledema in a child with Acute Lymphoblastic Leukaemia during remission-A Case Report
by: C Vivek Nandini Reddy, et al.
Published: (2020-01-01)

REMISSION RATE OF PRE-B ALL (ACUTE LYMPHOBLASTIC LEUKEMIA) AFTER INDUCTION CHEMOTHERAPY FOLLOWING UNITED KINGDOM ACUTE LYMPHOBLASTIC LEUKAEMIA 2011 (UKALL 2011) TRIAL PROTOCOL
by: Hafiz Muhammad Murtaza, et al.
Published: (2021-04-01)

Hypereosinophilia: A rare presentation of acute lymphoblastic leukaemia
by: G Narayanan, et al.
Published: (2018-01-01)

Next generation sequencing as a tool for pharmacogenomic profiling: Nine novel potential genetic markers for targeted therapy in childhood acute lymphoblastic leukemia
by: Dokmanović Lidija, et al.
Published: (2018-01-01)

Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response
by: Abaji R, et al.
Published: (2017-05-01)

TPMT Genetic Variability and Its Association with Hematotoxicity in Indonesian Children with Acute Lymphoblastic Leukemia in Maintenance Therapy
by: Rosdiana DS, et al.
Published: (2021-02-01)

Thiopurine S-methyltransferase activity in Nigerians: phenotypes and activity reference values
by: Ayorinde Adehin, et al.
Published: (2018-02-01)

Aggressive lung involvement in a patient with T‐acute lymphoblastic leukaemia/lymphoblastic lymphoma: a tricky and rare case report
by: Chika Miyaoka, et al.
Published: (2020-08-01)

The Role of Allograft in Acute Lymphoblastic Leukaemia, Including Alternate Donors
by: Julian Cooney
Published: (2017-08-01)

Patients in Focus: What's Relevant for Chronic Myeloid Leukaemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia?
by: Michele Baccarani, et al.
Published: (2017-08-01)

EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
by: Kjeld Schmiegelow
Published: (2011-05-01)

EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
by: Kjeld Schmiegelow
Published: (2011-01-01)

Multilocus genotypes of relevance for drug metabolizing enzymes and therapy with thiopurines in patients with acute lymphoblastic leukemia
by: Gabriele eStocco, et al.
Published: (2013-01-01)

B-Cell Acute Lymphoblastic Leukaemia of the Uterus
by: Eva Vanheule, et al.
Published: (2020-11-01)

The role of thiopurine methyltransferase in the metabolism of cytotoxic drugs
by: Coulthard, Sally Anne
Published: (2000)

Outcome of Childhood Acute Lymphoblastic Leukaemia after Induction Therapy --- Three-Year Experience in a Tertiary Care Hospital in Bangladesh
by: M Belayet Hossain, et al.
Published: (2017-01-01)

The use of biomarkers in detecting subclinical cardiotoxicity in doxorubicin-based treatment for paediatric patients with acute lymphoblastic leukaemia
by: Radu Letiția Elena, et al.
Published: (2017-04-01)

The clinical significance of current laboratory and other prognostic indicators in the management of South African children with Precursor B cell acute lymphoblastic leukaemia
by: Schapkaitz, Elise
Published: (2009)

In vitro studies of Thiopurine S-Methyltransferase: Ligand binding interactions and development of a new enzymatic activity assay for TPMTwt, TPMT*6 and TPMT*8
by: Hemmingsson, Lovisa, et al.
Published: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p8mt7a5eg5dofoq3u5fhoct7tv